Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-026873

General Counsel sold 1,048 shares at $23.35 ($24,471)

  • General Counsel acquired 45,710 shares (other)
  • General Counsel acquired 2,420 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Martin General Counsel 2024-05-14 Option exercise +2,420 21,100 D: show line 1 in the form
Wilson Martin General Counsel 2022-08-12 Other acquisition +28,763 49,863 D: show line 2 in the form
Wilson Martin General Counsel 2023-02-14 Other acquisition +16,947 66,810 D: show line 3 in the form
Wilson Martin General Counsel 2024-05-16 Sale −1,048 $23.35 $24,471 65,762 D: show line 4 in the form
Open-market sales · 1,048 sh · avg $23.35 · $24,471

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Wilson Martin General Counsel 2024-05-14 Option exercise · Restricted Stock Units −2,420 16,947 D: show line 5 in the form
Wilson Martin General Counsel 2022-08-12 Other disposition · Restricted Stock Units −28,763 0 D: show line 6 in the form
Wilson Martin General Counsel 2023-02-14 Other disposition · Restricted Stock Units −16,947 0 D: show line 7 in the form
Loading xslF345X05/form4.xml…